Literature DB >> 35700683

Educational programs in type 2 diabetes designed for community-dwelling older adults: A systematic review.

Veronica Izquierdo1, Marcos Pazos-Couselo2, María González-Rodríguez1, Raquel Rodríguez-González3.   

Abstract

AIMS: This systematic review aimed to assess the effectiveness of educational interventions in type 2 diabetes specifically designed for community-dwelling older adults.
METHODS: In accordance with PRISMA guidelines, a systematic search of studies published between 2010 and 2021 was conducted across five electronic databases and manual sources. The study protocol was previously registered in PROSPERO (CRD42021288236).
RESULTS: Twelve papers matched the inclusion criteria and were appraised using MERSQI. The features of the educational programs were heterogeneous, and none complied with the ten suggested standards for diabetes self-management education and support. Comprehensive gerontological assessment was not considered. Outcomes included biomedical, psychosocial, behavioral, and knowledge measures. HbA1c and knowledge showed improvements with a high certainty level according to GRADE.
CONCLUSIONS: Structured DSME programs aimed at older adults have great potential, however there is still room to improve. Applying the principles of a comprehensive gerontological approach and the standards for DSME as continuous monitoring and support could increase their benefits.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Comprehensive gerontological approach; Diabetes education; Intervention; Older adults; Self-management; Systematic review

Mesh:

Year:  2022        PMID: 35700683     DOI: 10.1016/j.gerinurse.2022.05.008

Source DB:  PubMed          Journal:  Geriatr Nurs        ISSN: 0197-4572            Impact factor:   2.525


  1 in total

1.  Multimodal Diabetes Empowerment for Older Adults with Diabetes.

Authors:  Keumok Park; Youngshin Song
Journal:  Int J Environ Res Public Health       Date:  2022-09-08       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.